Although amplification, rearrangement and overexpression of the Myc are rarely found in malignant gliomas [26, 27], the half life of Myc protein remains 4-6-fold elevated in a number of glioma cell lines, suggesting that Myc stabilization may be linked to the pathogenesis of GBM [28]. The gene discussed is MYC; the disease is central nervous system cancer.